BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15030573)

  • 21. Ethanol affects the generation, cosignaling molecule expression, and function of plasmacytoid and myeloid dendritic cell subsets in vitro and in vivo.
    Lau AH; Abe M; Thomson AW
    J Leukoc Biol; 2006 May; 79(5):941-53. PubMed ID: 16478920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited costimulatory molecule expression on renal tubular epithelial cells impairs T cell activation.
    Waeckerle-Men Y; Starke A; Wahl PR; Wüthrich RP
    Kidney Blood Press Res; 2007; 30(6):421-9. PubMed ID: 17975322
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycogen synthase kinase 3 activity during development of bone marrow-derived dendritic cells (DCs) essential for the DC function to induce T helper 2 polarization.
    Ono T; Yanagawa Y; Iwabuchi K; Nonomura K; Onoé K
    Immunology; 2007 Oct; 122(2):189-98. PubMed ID: 17490435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo.
    Levin D; Constant S; Pasqualini T; Flavell R; Bottomly K
    J Immunol; 1993 Dec; 151(12):6742-50. PubMed ID: 7903097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective antigen presenting activity of cortical thymic epithelial cells against CD4+ T cells associated with both lack of costimulatory molecules and inefficient presentation of MHC-peptide ligands.
    Kaneda R; Iwabuchi K; Kasai M; Murakami M; Uede T; Onoé K
    Cell Immunol; 1997 Nov; 181(2):163-71. PubMed ID: 9398403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. B7/CD28-dependent and -independent induction of CD40 ligand expression.
    Ding L; Green JM; Thompson CB; Shevach EM
    J Immunol; 1995 Dec; 155(11):5124-32. PubMed ID: 7594521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preparation of fully activated dendritic cells capable of priming tumor-specific cytotoxic T lymphocytes in patients with metastatic cancer using penicillin-killed streptococcus pyogenes (OK432) and anti-CD40 antibody.
    Kontani K; Teramoto K; Ozaki Y; Sawai S; Tezuka N; Ishida H; Kajino K; Fujino S; Yamauchi A; Taguchi O; Kannagi R; Yokomise H; Ogasawara K
    Oncol Rep; 2007 Apr; 17(4):895-902. PubMed ID: 17342333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD40 activation boosts T cell immunity in vivo by enhancing T cell clonal expansion and delaying peripheral T cell deletion.
    Maxwell JR; Campbell JD; Kim CH; Vella AT
    J Immunol; 1999 Feb; 162(4):2024-34. PubMed ID: 9973474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concerted antigen presentation by dendritic cells and B cells is necessary for optimal CD4 T-cell immunity in vivo.
    Kleindienst P; Brocker T
    Immunology; 2005 Aug; 115(4):556-64. PubMed ID: 16011524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ketamine inhibits maturation of bone marrow-derived dendritic cells and priming of the Th1-type immune response.
    Ohta N; Ohashi Y; Fujino Y
    Anesth Analg; 2009 Sep; 109(3):793-800. PubMed ID: 19690248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Split peripheral tolerance: CD40 ligation blocks tolerance induction for CD8 T cells but not for CD4 T cells in response to intestinal antigens.
    Chung Y; Ko SY; Ko HJ; Kang CY
    Eur J Immunol; 2005 May; 35(5):1381-90. PubMed ID: 15827964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cells genetically engineered to express IL-4 exhibit enhanced IL-12p70 production in response to CD40 ligation and accelerate organ allograft rejection.
    Kaneko K; Wang Z; Kim SH; Morelli AE; Robbins PD; Thomson AW
    Gene Ther; 2003 Jan; 10(2):143-52. PubMed ID: 12571643
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A role for CD40 expression on CD8+ T cells in the generation of CD8+ T cell memory.
    Bourgeois C; Rocha B; Tanchot C
    Science; 2002 Sep; 297(5589):2060-3. PubMed ID: 12242444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure and duration of contact between dendritic cells and T cells are controlled by T cell activation state.
    Rothoeft T; Balkow S; Krummen M; Beissert S; Varga G; Loser K; Oberbanscheidt P; van den Boom F; Grabbe S
    Eur J Immunol; 2006 Dec; 36(12):3105-17. PubMed ID: 17111349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.
    Constant S; Schweitzer N; West J; Ranney P; Bottomly K
    J Immunol; 1995 Oct; 155(8):3734-41. PubMed ID: 7561077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy.
    Feili-Hariri M; Falkner DH; Morel PA
    J Leukoc Biol; 2005 Sep; 78(3):656-64. PubMed ID: 15961574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC class II-expressing hepatocytes function as antigen-presenting cells and activate specific CD4 T lymphocyutes.
    Herkel J; Jagemann B; Wiegard C; Lazaro JF; Lueth S; Kanzler S; Blessing M; Schmitt E; Lohse AW
    Hepatology; 2003 May; 37(5):1079-85. PubMed ID: 12717388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B lymphocytes as antigen-presenting cells for CD4+ T cell priming in vivo.
    Constant SL
    J Immunol; 1999 May; 162(10):5695-703. PubMed ID: 10229801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.